Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society

Overview of attention for article published in Journal of Neurology, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy: 1 policy source
twitter: 1 X user

patent: 1 patent

Readers on

mendeley: 411 Mendeley

Summary Policy documents X Patents

So far, Altmetric has seen 1 patent that references this research output.

METHODS FOR TREATMENT OF REFRACTORY GENERALIZED MYASTHENIA GRAVIS WITH ECULIZUMAB

Application WO-2021026160-A1

World Intellectual Property Organisation (WIPO)